Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Sarah Grillo/Axios
The coronavirus has sparked a new and highly competitive vaccine-development race, but competition in the sector had previously been declining for years, according to a report from the liberal Open Markets Institute, which was shared with Axios.
By the numbers: The number of drug companies producing vaccines shrunk considerably in the '80s and '90s, according to the report, leaving just eight companies producing recommended childhood vaccines in 1996.
- That number dwindled to just 4 manufacturers by 2002, when several childhood vaccines went into shortage.
The big picture: When the U.S. faced a shortage of flu vaccines in 2004, a big cash infusion from the federal government helped boost production. The billions of taxpayer dollars on offer now through Operation Warp Speed have once again helped jump-start vaccine work.
- But it has lagged when federal money hasn't been there to prop it up.